IGC Pharma, Inc. Annual Depreciation, Depletion and Amortization in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
IGC Pharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2010 to 2023.
- IGC Pharma, Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2024 was $162K, a 4.52% increase year-over-year.
- IGC Pharma, Inc. annual Depreciation, Depletion and Amortization for 2023 was $637K, a 3.04% decline from 2022.
- IGC Pharma, Inc. annual Depreciation, Depletion and Amortization for 2022 was $657K, a 0.92% increase from 2021.
- IGC Pharma, Inc. annual Depreciation, Depletion and Amortization for 2021 was $651K, a 36.2% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)